Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)
NCT ID: NCT06696443
Last Updated: 2025-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
PHASE3
300 participants
INTERVENTIONAL
2024-12-18
2027-01-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
NCT06628908
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
NCT07231419
Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)
NCT05660538
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
NCT06619860
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
NCT00044408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suzetrigine (SUZ)
Participants will receive SUZ once daily (qd) up to 52 weeks.
Suzetrigine
Tablets for oral administration.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Suzetrigine
Tablets for oral administration.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of drug intolerance in a parent study that would pose an additional risk to the participant in the opinion of the investigator
* Current participation in an investigational drug trial (other than a parent study)
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vertex Pharmaceuticals Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pinnacle Research Group, LLC
Anniston, Alabama, United States
AMR Daphne, AL
Daphne, Alabama, United States
Scottsdale Clinical Trials
Scottsdale, Arizona, United States
Neuro-Pain Medical Center
Fresno, California, United States
Long Beach Research Institute
Long Beach, California, United States
Angel City Research, Inc
Los Angeles, California, United States
Empire Clinical Research
Pomona, California, United States
Clinical Trials Research
Sacramento, California, United States
Velocity Clinical Research, San Bernardino
San Bernardino, California, United States
SCLA Management - Pain Management and Injury Relief
Thousand Oaks, California, United States
Velocity Clinical Research - Denver
Englewood, Colorado, United States
Velocity Clinical Research - Washington DC
Washington D.C., District of Columbia, United States
AMR-Miami
Coral Gables, Florida, United States
Accel Research - Deland
DeLand, Florida, United States
Suncoast Research Associates - Miami
Doral, Florida, United States
AMR Fort Myers (The Clinical Study Center)
Fort Myers, Florida, United States
Velocity Clinical Research - Hallandale Beach
Hallandale, Florida, United States
CNS Healthcare - Jacksonville
Jacksonville, Florida, United States
Accel Research Site - St. Petersburg/Largo
Largo, Florida, United States
Accel Research Sites - Maitland
Maitland, Florida, United States
3Sync Research - Miami Lakes
Miami Lakes, Florida, United States
Suncoast Clinical Research - New Port Richey
New Port Richey, Florida, United States
Conquest Clinical Research - Orlando - Neuro
Orlando, Florida, United States
Conquest Clinical Research - Winter Park
Winter Park, Florida, United States
Accel Research - Decatur
Decatur, Georgia, United States
Velocity Clinical Research - Boise
Meridian, Idaho, United States
Feinberg School of Medicine - Anesthesiology
Chicago, Illinois, United States
Healthcare Research Network - Flossmoor IL
Tinley Park, Illinois, United States
Synexus Clinical Research - Evansville
Evansville, Indiana, United States
AMR Wichita East, KS (Heartland Research Associates)
Wichita, Kansas, United States
AMR Lexington
Lexington, Kentucky, United States
Velocity Clinical Research - Baton Rouge
Baton Rouge, Louisiana, United States
Tandem Clinical Research- Covington
Covington, Louisiana, United States
Mass General Brigham - Brigham and Women's Hospital - Main Campus
Boston, Massachusetts, United States
MedVadis Research Corporation
Waltham, Massachusetts, United States
Healthcare Research Network - Hazelwood MO
Hazelwood, Missouri, United States
AMR Kansas City
Kansas City, Missouri, United States
Velocity Clinical Research - Norfolk
Norfolk, Nebraska, United States
HRI - Hassman Research Institute
Marlton, New Jersey, United States
Velocity Clinical Research - Albuquerque
Albuquerque, New Mexico, United States
Swift Clinical OpCo, Inc
Brooklyn, New York, United States
Velocity Clinical Research - Syracuse
East Syracuse, New York, United States
Synexus Clinical Research - New York (DRS)
New York, New York, United States
Columbia Presbyterian - The Neurological Institute of New York
New York, New York, United States
West Clinical Research
Morehead City, North Carolina, United States
Eximia Research - Raleigh
Raleigh, North Carolina, United States
Carolinas Pain Institute - Winston-Salem Office
Winston-Salem, North Carolina, United States
Velocity Clinical Research - Cleveland
Beachwood, Ohio, United States
Synexus Clinical Research - Cincinnati
Cincinnati, Ohio, United States
META Medical Research Institute
Dayton, Ohio, United States
Velocity Clinical Research - Medford
Medford, Oregon, United States
Suburban Research Associates - Media
Media, Pennsylvania, United States
Velocity Clinical Research - Providence
East Greenwich, Rhode Island, United States
Synexus Clinical Research- Anderson
Anderson, South Carolina, United States
Clinical Trials of South Carolina - Charleston
Charleston, South Carolina, United States
M3 Wake Research - Charleston
Charleston, South Carolina, United States
Velocity Clinical Research - Spartanburg
Spartanburg, South Carolina, United States
Zenos Clinical Research
Dallas, Texas, United States
Be Well Clinical Studies - Austin
Round Rock, Texas, United States
San Antonio Clinical Trials
San Antonio, Texas, United States
Velocity Clinical Research - Waco
Waco, Texas, United States
Kalo Clinical Research - Salt Lake City
Salt Lake City, Utah, United States
Velocity Clinical Research - Salt Lake City
West Jordan, Utah, United States
Dominion Medical Associates, Inc.
Richmond, Virginia, United States
Northwest Clinical Research Center (NWCRC)
Bellevue, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VX24-548-112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.